RxDoctor Payments DataLook up a doctor →

Suraj Gathani, MD

Family Medicine · Louisville, KYNPI 1902172067

Payments from drug & device makers

$69,406in general payments, 2019–2025

Across 1,576 payments — averaging $44.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Phathom Pharmaceuticals, Inc.$22K
  • Biohaven Pharmaceutical Holding Company Ltd.$12K
  • Biohaven Pharmaceuticals, Inc.$10K
  • AbbVie$7K
  • Bausch Health US, LLC$2K
  • Novo Nordisk$2K
  • plus $14K from 51 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Phathom Pharmaceuticals, Inc.90$21,584
Biohaven Pharmaceutical Holding Company Ltd.72$12,389
Biohaven Pharmaceuticals, Inc.41$10,451
AbbVie(2 entities)215$7,384
Bausch Health US, LLC158$1,907
Novo Nordisk119$1,738
Amgen(2 entities)95$1,638
AstraZeneca33$1,438
Pfizer104$1,160
Lilly USA, LLC88$1,120
Boehringer Ingelheim81$961
Takeda Pharmaceuticals U.S.A., Inc.69$918
Bayer40$680
GSK48$593
Amarin Pharma, Inc.39$540
Mylan Specialty L.p.28$456
Novartis28$440
Sanofi-aventis U.S. LLC23$336
Johnson & Johnson20$331
Merck27$295
Kerecis Limited3$285
Convatec Inc.7$253
Exact Sciences15$228
E.r. Squibb & Sons, L.L.C.9$153
Esperion Therapeutics, Inc.9$145
Urgo Medical North America, LLC7$140
Dynavax Technologies Corporation9$140
Azurity Pharmaceuticals, Inc.7$132
Paratek Pharmaceuticals, Inc.6$132
Astellas Pharma US Inc8$120
Aytu Biopharma, Inc.11$110
Axsome Therapeutics, Inc.5$96
Idorsia Pharmaceuticals US Inc6$90
Abbott5$86
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$78
Radius Health, Inc.4$74
Philips North America LLC5$69
Corcept Therapeutics4$69
Viatris Specialty LLC3$68
Kowa Pharmaceuticals America, Inc.4$64
Sanofi1$60
Supernus Pharmaceuticals, Inc.4$59
Neos Therapeutics, LP3$55
Vanda Pharmaceuticals Inc.2$50
Smith+Nephew1$48
Arbor Pharmaceuticals, Inc.3$42
IBSA Pharma Inc.3$40
Averitas Pharma Inc.1$20
Nevro Corp.1$19
Biodelivery Sciences International, Inc.1$19
Antares Pharma, Inc.1$18
Verona Pharma, Inc.1$16
Ironshore Pharmaceuticals Inc.1$16
Alfasigma USA, Inc.1$15
Melinta Therapeutics, LLC1$14
Genentech USA, Inc.1$13
Sanofi Pasteur Inc.1$11

How this compares

$69,406 in reported general payments places this provider in the 95th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky →

Medicare billing

Part B allowed, 2024
$107,506
Medicare patients
197
Services billed
1,373

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Louisville

See the full list for Kentucky →

Where these figures come from

Is this you, or does something look wrong? →